Hepatitis c dating indiana
The pricing and launch of the breakthrough treatment of hepatitis C is crucial for India, which has one of the highest incidence of the virus, with over 12 million chronically infected, according to WHO.
Gilead also plans to license its new therapy to Indian generic manufacturers, who will then supply lower cost versions of the drug in the country, and across global markets.
A patient group, Delhi Network of Positive People, and UK-based intellectual property law firm, Initiative for Medicines Access and Knowledge, have together filed an opposition to prevent Gilead from gaining a patent in India.
Because HCV infection usually produces no symptoms or very mild symptoms during the early stages, many people don’t know they have it until liver damage shows up – sometimes decades later – during routine medical tests.
You only have one liver and it’s one of the largest and most important organs in your body.
Your liver is located behind the lower right part of your ribs, which help protect it.
Twenty percent of cases will develop serious liver damage from hepatitis C, and 25 percent of those will need a liver transplant, develop liver cancer, or die.
In order to understand your Hepatitis C infection, it helps to have a basic understanding of how your liver works.
Eighty-five percent of infected individuals will be asymptomatic for decades.
Symptoms that can be present during acute infection include nausea, vomiting, fever, chills, abdominal pain, and/or jaundice.
Laboratory reports often do not include racial information.
In 2005, race was not reported for over 40 percent of hepatitis C cases; consequently, an accurate comparison is not possible.
At present, the company has initiated clinical trials of the drug in India, with results expected in 2015-end.